Literature DB >> 7980574

Influence of MA internal sequences, but not of the myristylated N-terminus sequence, on the budding site of HIV-1 Gag protein.

A Gallina1, G Mantoan, G Rindi, G Milanesi.   

Abstract

HIV-1 Gag protein intracellular transport and budding was investigated by altering the sequence of the MA domain, which directly bears an essential N-terminal myristyl adduct and forms the viral matrix after Gag proteolysis in mature virions. We found that removal of a substantial MA internal segment did not abolish the assembly and budding of Gag particles, but rather diverted these events to intracellular cisternae. The internally deleted Gag was further modified by substituting either of two heterologous myristylated N-termini for the natural one: amino acids 1-12 from v-Src oncoprotein (for which a membrane-bound intracellular receptor has been postulated), or amino acids 1-12 from Poliovirus polyprotein (for which no membrane-targeting function has been demonstrated). Both Src-Gag and Polio-Gag chimerae exhibited transport and processing characteristics similar to those of the MA-deleted Gag. These results are discussed with respect to the possible transport pathway of HIV-1 Gag.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7980574     DOI: 10.1006/bbrc.1994.2566

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  Binding of human immunodeficiency virus type 1 Gag to membrane: role of the matrix amino terminus.

Authors:  A Ono; E O Freed
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

2.  Role of matrix in an early postentry step in the human immunodeficiency virus type 1 life cycle.

Authors:  R E Kiernan; A Ono; G Englund; E O Freed
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

3.  The Nef protein of human immunodeficiency virus type 1 enhances serine phosphorylation of the viral matrix.

Authors:  S Swingler; P Gallay; D Camaur; J Song; A Abo; D Trono
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

4.  Plasma membrane targeting of chimeric intracisternal A-type particle polyproteins leads to particle release and specific activation of the viral proteinase.

Authors:  R Welker; A Janetzko; H G Krausslich
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

5.  Specificity of plasma membrane targeting by the rous sarcoma virus gag protein.

Authors:  Lisa Z Scheifele; Jonathan D Rhoads; Leslie J Parent
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

6.  Role of the Gag matrix domain in targeting human immunodeficiency virus type 1 assembly.

Authors:  A Ono; J M Orenstein; E O Freed
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

7.  Phosphoinositides direct equine infectious anemia virus gag trafficking and release.

Authors:  Fiona Fernandes; Kang Chen; Lorna S Ehrlich; Jing Jin; Min H Chen; Gisselle N Medina; Marc Symons; Ronald Montelaro; Julie Donaldson; Nico Tjandra; Carol A Carter
Journal:  Traffic       Date:  2011-02-01       Impact factor: 6.215

8.  Tailored HIV-1 vectors for genetic modification of primary human dendritic cells and monocytes.

Authors:  Stéphanie Durand; Xuan-Nhi Nguyen; Jocelyn Turpin; Stephanie Cordeil; Nicolas Nazaret; Séverine Croze; Renaud Mahieux; Joël Lachuer; Catherine Legras-Lachuer; Andrea Cimarelli
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

Review 9.  The tale of the long tail: the cytoplasmic domain of HIV-1 gp41.

Authors:  Thomas S Postler; Ronald C Desrosiers
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

10.  Cell-type-dependent targeting of human immunodeficiency virus type 1 assembly to the plasma membrane and the multivesicular body.

Authors:  Akira Ono; Eric O Freed
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.